RRRobert S. Ross

Robert S. Ross

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Robert S. Ross has a total of 470 co-authors. Here are the top co-authors by number of shared publications:

  • Ana Maria Manso

    Division of Cardiovascular Medicine, Department of Medicine

    13 shared publications
  • Nancy D. Dalton

    From the Department of Medicine (J.Z., A.K.P., M.K., H.C., S.M.H., J.K.T., D.F., Y.G., N.D.D., Y.C., J.K.T., D.F., Y.G., N.D.D., Y.C., R.L., K.L.P., J.C., A.D.M., R.S.R.), University of California San Diego, La Jolla, CA

    7 shared publications
  • Shaw-Yung Shai

    7 shared publications
  • Joshua I. Goldhaber

    Department of Cardiology, Cedars-Sinai Medical Center, Los Angeles, CA (J.I.G.).

    6 shared publications
  • Ju Chen

    Division of Cardiovascular Medicine, Department of Medicine, University of California, San Diego, La Jolla, CA, 92093, USA

    6 shared publications
  • Ruixia Li

    Division of Cardiovascular Medicine, Department of Medicine, University of California, San Diego, La Jolla (S.T., R.L., A.L., J.C., D.J., R.S.R., Y.C.).

    6 shared publications

Latest Publications

  • Open Access

    Cardiomyocyte Perm1 sustains cardiac bioenergetic reserve and exercise capacity

    by Shizuko Tachibana, Tina Le, Simon Schenk, Wei Feng, Ju Chen, Robert S. Ross, Stephan Lange, Yoshitake Cho

    Objective: The PGC-1/ERR axis controls both steady-state mitochondrial respiration and the capacity to expand ATP production on demand, but whether this reserve function requires dedicated downstream effectors, and whether its loss is detectable at rest, remain unclear. We tested whether Perm1, a striated muscle-specific PGC-1/ERR-induced regulator, is required for cardiac bioenergetic reserve. Methods: We generated cardiomyocyte-specific Perm1 knockout mice using constitutive αMHC-nCre and tamoxifen-inducible αMHC-MerCreMer drivers and followed to 12 months and to 4 months after tamoxifen, respectively. Mitochondrial respiration was measured by high-resolution respirometry and ultrastructure by electron microscopy; energetic capacity under load was tested by treadmill exercise with tissue ATP quantification and by β-adrenergic stimulation of neonatal cardiomyocytes. Results: Perm1 deletion did not perturb cardiac development; neither constitutive nor adult-onset deletion impaired cardiac structure and systolic function through 12 months. Despite this, mitochondrial respiration was reduced by 20–25% without a change in total mitochondrial content or OxPhos subunit abundance. MICOS components MIC60 and MIC19 were selectively reduced, and mitochondria redistributed from subsarcolemmal to interfibrillar compartments. Perm1-deficient mice of both sexes showed ∼50% lower treadmill endurance at 6 and 12 months and failed to maintain cardiac ATP at a submaximal workload, whereas gastrocnemius ATP and plasma lactate were unaffected. β-Adrenergic stimulation raised ATP content in control cardiomyocytes, and Perm1 knockdown blunted this response. Conclusions: Perm1 is a cardiomyocyte-intrinsic determinant of cardiac bioenergetic reserve: dispensable for resting function but required to expand ATP production when demand rises. This regulation is invisible to resting phenotyping and emerges only under stress.

  • Open Access

    Regulation of Pacemaker Current in the Sinoatrial Node by Zonula Occludens-1

    by Rui Zhang, Sarah Teboull, Dexin Chen, Peixin He, Seho Kim, Liang Li, Daniel Adolfo, Terence Gee, Robert S. Ross, Joshua I. Goldhaber

    BACKGROUND: In addition to lethal ventricular arrhythmias, arrhythmogenic cardiomyopathy (ACM) is associated with conduction abnormalities, bradycardias, and reduced expression of the scaffolding junctional protein zonula occludens-1 (ZO-1). Reduced ZO-1 expression is also seen in dilated cardiomyopathy, which is far more common than ACM. Conduction abnormalities are likewise a feature of ZO-1 cardiac-specific knockout (ZO-1cKO) mice. However, the role of ZO-1 in sinoatrial node (SAN) automaticity has not been studied. OBJECTIVE: To investigate the role of ZO-1 in SAN automaticity and elucidate the mechanisms by which ZO-1 deficiency leads to SAN dysfunction. METHODS: ZO-1 cardiac-specific knockout (ZO-1cKO) mice were generated by crossing ZO-1 floxed mice with αMHC-nuclear Cre mice. SAN/atrial tissue and isolated SAN cells were examined using optical mapping, single-cell patch clamp, and quantitative PCR techniques to assess functional alterations caused by ZO-1 loss. RESULTS: ZO-1cKO mice exhibited enlarged atria and SAN area compared to control mice, with normal left ventricular function. Electrocardiograms showed sinus bradycardia, sinus pauses and atrioventricular block. Optical mapping revealed a caudal shift in the SAN leading region and reduced intra-atrial conduction velocity in ZO-1cKO mice. Patch-clamp recordings from isolated SAN cells showed reduced spontaneous action potential frequency and diastolic depolarization rate, while voltage-clamp revealed a marked reduction in pacemaker current (I f ). CONCLUSION: ZO-1 expression is essential for SAN automaticity. Its loss impairs SAN impulse generation by reducing pacemaker current and hampering atrial conduction, leading to bradyarrhythmia, conduction delay and block. These findings help explain impulse generation and conduction abnormalities in ACM and other cardiomyopathies.

  • Open Access

    Human Variant in the Cardiac Troponin I Switch Domain Causes Diastolic Dysfunction in a Novel Mouse Model

    by Elizabeth Silver, Jason M. Duran, Betul Beyza Gunes, Axel J. Fenwick, Sofie Maisel, Tsui‐Min Wang, Ana Maria Manso, Marina Sampaio Cruz, Yusu Gu, Joshua Fong, et al.


  • Perm1 Protects the Heart From Pressure Overload–Induced Dysfunction by Promoting Oxidative Metabolism

    by Shizuko Tachibana, Nam-Kyung Yu, Ruixia Li, Carolina Fernandez-Costa, Alex Liang, Janet Choi, Dayoen Jung, Changchun Xiao, Anastasia Kralli, John R. Yates, et al.


  • Integrins in Cardiac Form, Function, and Disease

    by Ana Maria Manso, Andreas Romaine, Geir Christensen, Robert S. Ross


  • Open Access

    Integrating Integrins

    by Robert S. Ross


  • Cardiomyocyte Expression of ZO-1 Is Essential for Normal Atrioventricular Conduction but Does Not Alter Ventricular Function

    by Jianlin Zhang, Kevin P. Vincent, Angela Kay Peter, Matthew Klos, Hongqiang Cheng, Selina Manying Huang, Jordan Kelly Towne, Debbie Ferng, Yusu Gu, Nancy D. Dalton, et al.

    Rationale: ZO-1 (Zonula occludens-1), a plasma membrane-associated scaffolding protein regulates signal transduction, transcription, and cellular communication. Global deletion of ZO-1 in the mouse is lethal by embryonic day 11.5. The function of ZO-1 in cardiac myocytes (CM) is largely unknown. Objective: To determine the function of CM ZO-1 in the intact heart, given its binding to other CM proteins that have been shown instrumental in normal cardiac conduction and function. Methods and Results: We generated ZO-1 CM-specific knockout (KO) mice using α-Myosin Heavy Chain-nuclear Cre (ZO-1cKO) and investigated physiological and electrophysiological function by echocardiography, surface ECG and conscious telemetry, intracardiac electrograms and pacing, and optical mapping studies. ZO-1cKO mice were viable, had normal Mendelian ratios, and had a normal lifespan. Ventricular morphometry and function were not significantly different between the ZO-1cKO versus control (CTL) mice, basally in young or aged mice, or even when hearts were subjected to hemodynamic loading. Atrial mass was increased in ZO-1cKO. Electrophysiological and optical mapping studies indicated high-grade atrioventricular (A-V) block in ZO-1cKO comparing to CTL hearts. While ZO-1-associated proteins such as vinculin, connexin 43, N-cadherin, and α-catenin showed no significant change with the loss of ZO-1, Connexin-45 and Coxsackie-adenovirus (CAR) proteins were reduced in atria of ZO-1cKO. Further, with loss of ZO-1, ZO-2 protein was increased significantly in ventricular CM in a presumed compensatory manner but was still not detected in the AV nodal myocytes. Importantly, the expression of the sodium channel protein NaV1.5 was altered in AV nodal cells of the ZO-1cKO versus CTL. Conclusions: ZO-1 protein has a unique physiological role in cardiac nodal tissue. This is in alignment with its known interaction with CAR and Cx45, and a new function in regulating the expression of NaV1.5 in AV node. Uniquely, ZO-1 is dispensable for function of the working myocardium.


  • Open Access

    Mechanical Instability of Adherens Junctions Overrides Intrinsic Quiescence of Hair Follicle Stem Cells

    by Ritusree Biswas, Avinanda Banerjee, Sergio Lembo, Zhihai Zhao, Vairavan Lakshmanan, Manando Nakasaki, Vassily Kutyavin, Graham Wright, Dasaradhi Palakodeti, Robert Ross, et al.

    Vinculin, a mechanotransducer associated with both adherens junctions (AJ) and focal adhesions (FA) plays a central role in force transmission through these cell-cell and cell-substratum contacts. Here we describe the conditional knock out (KO) of vinculin in murine skin. Remarkably, we find that the loss of vinculin function results in the loss of bulge stem cell (BuSC) quiescence. We demonstrate that vinculin KO cells are impaired in force generation resulting in mechanically weak AJs. Mechanistically, vinculin functions by keeping α-catenin in a stretched conformation, which in turn regulates the retention of YAP1, another potent mechanotransducer and regulator of cell proliferation, to the junctions. Conditional KO of α-catenin specifically in the BuSCs further corroborates the importance of stable AJs in the maintenance of quiescence and stemness. Altogether, our data provides definitive mechanistic insights into the hitherto unexplored regulatory link between the mechanical stability of cell-junctions and the maintenance of BuSC quiescence.

  • Open Access

    Vinculins interaction with talin is essential for mammary epithelial differentiation

    by Pengbo Wang, Jian Wu, Amber Wood, Matthew Jones, Robert Pedley, Weiping Li, Robert S. Ross, Christoph Ballestrem, Andrew P. Gilmore, Charles H. Streuli

    Vinculin is an essential component of cell adhesion complexes, where it regulates the strength and stability of adhesions. Whilst the role of vinculin in cell motility is well established, it remains unclear how vinculin contributes to other aspects of tissue function. Here we examine the role of vinculin in mammary epithelial cell phenotype. In these cells, correct adhesion to the extracellular matrix is essential for both the formation of polarised secretory acini and for the transcription of tissue-specific milk protein genes. We show that vinculin, through its interaction with talin, controls milk protein gene expression. However, vinculin is not required for the formation of polarised acini. This work reveals new roles for vinculin that are central to cellular differentiation, and for the ability of cells to interpret their extracellular microenvironment.


  • Talin and Kindlin as Integrin-Activating Proteins: Focus on the Heart

    by Chao Chen, Ana Maria Manso, Robert S. Ross

    Integrin receptors enable cells to sense and respond to their chemical and physical environment. As a class of membrane receptors, they provide a dynamic, tightly regulated link between the extracellular matrix or cellular counter-receptors and intracellular cytoskeletal and signaling networks. They enable transmission of mechanical force across the plasma membrane, and particularly for cardiomyocytes, may sense the mechanical load placed on cells. Talins and Kindlins are two families of FERM—domain proteins which bind the cytoplasmic tail of integrins, recruit cytoskeletal and signaling proteins involved in mechano-transduction, and those which synergize to activate integrins, allowing the integrins to physically change and bind to extracellular ligands. In this review, we will discuss the roles of talin and kindlin, particularly as integrin activators, with a focus on cardiac myocytes.